M&A / Deals Syneron raises $150m for macrocyclics, and other financings PharmaphorumOur round-up of recent biotech venture capital financings includes nine-figure rounds for Syneron, Stipple Bio, and Sidewinder.M&A / DealsRead full story pharminent April 9, 2026 (Last updated: April 9, 2026) Pharmaphorum Our round-up of recent biotech venture capital financings includes nine-figure rounds for Syneron, Stipple Bio, and Sidewinder. M&A / DealsRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Shionogi secures $482m BARDA contract to tackle AMR crisisNext: FDA seeks permanent future for rare pediatric priority review vouchers Related Stories M&A / Deals J&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout pharminent July 31, 2026 M&A / Deals Eisai and CORE Biomedicine agree on global licence for oncology pipeline pharminent July 29, 2026 M&A / Deals Argenx signs agreement to buy Forte Biosciences for $2.2bn pharminent July 28, 2026
